H

HDT Bio

32 employees

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2018

Funding rounds raised

Total raised

$49M

from 4 investors over 4 rounds

H

HDT Bio raised $49M on November 30, 2022

Investors: Medical CBRN Defense Consortium

H

HDT Bio raised $2.9M on May 17, 2021

Investors: National Institutes of Health

H

HDT Bio raised $4M on October 5, 2020

Investors: Zoic Capital

H

HDT Bio raised $8.3M on September 1, 2020

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ